Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as a Component of Combined Treatment in Patients With Advanced Epithelial Ovarian Cancer and Peritoneal Carcinomatosis: A Randomized Phase II Trial (PrimPIPAC)

NCT07514494 is registered in ClinicalTrials.gov with Moscow Regional Oncological Dispensary as lead sponsor.

NCT NCT07514494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as a Component of Combined Treatment in Patients With Advanced Epithelial Ovarian Cancer and Peritoneal Carcinomatosis: A Randomized Phase II Trial (PrimPIPAC)
Lead sponsor
Moscow Regional Oncological Dispensary
Phase
Phase 2
Overall status
Recruiting
Start date
April 2, 2025
Completion date
April 2, 2030
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced epithelial ovarian cancer, peritoneal carcinomatosis